Literature DB >> 6131753

Actions of calcium antagonists on calcium currents in Helix neurons. Specificity and potency.

K Nishi, N Akaike, Y Oyama, H Ito.   

Abstract

We have examined the effects of organic Ca++ channel blockade on calcium currents in Helix neurones, using a suction pipette technique which allows internal perfusion of the cell body and voltage clamp. In experiments on large cells with large currents, a microelectrode was used to measure membrane potential and provide the feedback potential for the voltage clamp. Calcium current was recorded after suppression of Na+ and K+ currents. The Ca++ conductance transports Ca++ and other divalent cations, such as Sr++, Ba++, Mn++, Zn++ and Cd++. Calcium current is temperature-dependent, and the Q10 of peak current was about 2.5. The organic Ca++ antagonists, verapamil, diltiazem, and nifedipine, inhibit calcium currents over the entire range of the current-voltage relationship. The effects are dose-dependent and there is no shifting in the current-voltage curves. Increases in extracellular Ca++ overcame the inhibitory action of the agents. Double reciprocal plots for peak calcium currents vs. external Ca++ concentrations in the presence or absence of diltiazem indicated competition with Ca++ at a common binding site. Intracellular application of diltiazem inhibited calcium currents.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131753

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  12 in total

1.  D600 blocks the Ca2+ channel from the outer surface of smooth muscle cell membrane of the rabbit intestine and portal vein.

Authors:  Y Ohya; K Terada; K Kitamura; H Kuriyama
Journal:  Pflugers Arch       Date:  1987-01       Impact factor: 3.657

2.  Voltage-dependent calcium current in dissociated smooth muscle cells of the buccal mass of Aplysia.

Authors:  J L Ram; L X Liu
Journal:  J Comp Physiol B       Date:  1991       Impact factor: 2.200

3.  Trifluoperazine enhancement of Ca2+-dependent inactivation of L-type Ca2+ currents in Helix aspersa neurons.

Authors:  H Cruzblanca; S M Gamiño; J Bernal; F J Alvarez-Leefmans
Journal:  Invert Neurosci       Date:  1998-03

4.  Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.

Authors:  S Tokuyama; I K Ho
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

5.  Inhibitory actions of diltiazem and its derivative, TA3090 on the Ba-current recorded from smooth muscle cells of the rabbit mesenteric artery.

Authors:  Z Xiong; T Sakai; Y Inoue; K Kitamura; H Kuriyama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

6.  Changes in the contractile responses to carbachol and in the inhibitory effects of verapamil and nitrendipine on isolated smooth muscle preparations from rats subchronically exposed to Co2+ and Ni2+.

Authors:  P P Vassilev; K Venkova; N Pencheva; D Staneva-Stoytcheva
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  Evidence for verapamil-induced functional inhibition of noradrenergic neurotransmission in vivo.

Authors:  S Gurtu; S Seth; A K Roychoudhary
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

8.  Different inhibitions of the voltage-dependent K+ current by Ca2+ antagonists in the smooth muscle cell membrane of rabbit small intestine.

Authors:  K Terada; K Kitamura; H Kuriyama
Journal:  Pflugers Arch       Date:  1987-05       Impact factor: 3.657

9.  Calcium agonist (BayK 8644) augments voltage-sensitive calcium currents but not synaptic transmission in cultured mouse spinal cord neurons.

Authors:  C Yu; M Jia; M Litzinger; P G Nelson
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

10.  Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.

Authors:  M Barrios; I Robles; J M Baeyens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.